1.66
3.11%
0.05
After Hours:
1.66
Accelerate Diagnostics Inc Stock (AXDX) Forecast
The Accelerate Diagnostics Inc (AXDX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.704, representing a -57.59% decrease from the current price of $1.66. The highest analyst price target is $0.8504, and the lowest is $0.5575.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AXDX Price Target
Average 4.0807
(+145.83% Upside)
Is Accelerate Diagnostics Inc (AXDX) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 40.44 | Neutral |
STOCH(9,6) | 15.31 | Buy |
STOCHRSI(14) | 24.77 | Neutral |
MACD(12,26) | -0.0552 | Sell |
ADX(14) | 19.08 | Neutral |
William %R | -80.53 | Buy |
CCI(14) | -66.80 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
1.697
Sell
|
1.6982
Sell
|
MA20 |
1.8103
Sell
|
1.7551
Sell
|
MA50 |
1.8017
Sell
|
1.7595
Sell
|
MA100 |
1.6532
Buy
|
1.7006
Sell
|
MA200 |
1.3505
Buy
|
2.1513
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, AXDX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AXDX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.44 indicates that AXDX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.31 indicates that AXDX is oversold. This indicates that AXDX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.77 indicates that AXDX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.08 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.8 indicates that AXDX is still oversold but not to an extreme extent.
Long-term AXDX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Accelerate Diagnostics Inc financial reports and earnings history, Accelerate Diagnostics Inc (AXDX) stock could reach $18.94 by 2030, $14.29 by 2040 and $43.00 by 2050. See the projected annual prices until 2050 of the Accelerate Diagnostics Inc stock below:
- Accelerate Diagnostics Inc (AXDX) is expected to reach an average price of $0.5754 in 2035, with a high prediction of $0.6217 and a low estimate of $0.0112. This indicates an $-65.34% rise from the last recorded price of $1.66.
- Accelerate Diagnostics Inc (AXDX) stock is projected to chart a bullish course in 2040, with an average price target of $13.56, representing an $716.58% surge from its current level. The forecast ranges from a conservative $13.78 to a sky-high $14.29.
- Our analysts predict Accelerate Diagnostics Inc (AXDX) to jump 1,468% by 2045, soaring from $26.18 to an average price of $26.03, potentially reaching $26.40. While $26.18 is the low estimate, the potential upside is significant.
- Accelerate Diagnostics Inc (AXDX) stock is expected to climb by 2050, reaching an average of $42.97, a $2,489% jump from its current level. However, a wide range of estimates exists, with high and low targets of $43.00 and $43.32, respectively, highlighting the market's uncertainty.
Accelerate Diagnostics Inc Stock (AXDX) Year by Year Forecast
Accelerate Diagnostics Inc Stock (AXDX) Price Forecast for 2025
Accelerate Diagnostics Inc Stock (AXDX) is expected to reach an average price of $4.0807 in 2025, with a high prediction of $8.0174 and a low estimate of $0.1441. This indicates an +145.83% rise from the last recorded price of $1.66.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $0.0825 | $0.5575 | $0.8504 | -95.03% |
February, 2025 | $0.0346 | $0.2043 | $1.9389 | -97.91% |
March, 2025 | $3.8167 | $0.1514 | $1.0786 | +129.92% |
April, 2025 | $8.1856 | $4.6785 | $7.7789 | +393.11% |
May, 2025 | $6.6577 | $6.8627 | $8.0174 | +301.07% |
June, 2025 | $6.9348 | $5.36 | $5.2998 | +317.76% |
July, 2025 | $3.0037 | $6.5437 | $6.6334 | +80.95% |
August, 2025 | $1.4792 | $0.1441 | $3.2859 | -10.89% |
September, 2025 | $0.6321 | $0.2856 | $3.9924 | -61.92% |
October, 2025 | $3.6318 | $0.7747 | $2.3451 | +118.79% |
November, 2025 | $3.6989 | $3.8189 | $3.2886 | +122.83% |
December, 2025 | $4.6228 | $3.5193 | $4.0128 | +178.48% |
Accelerate Diagnostics Inc Stock (AXDX) Price Forecast for 2026
The predicted value for Accelerate Diagnostics Inc (AXDX) in 2026 is set at an average of $3.3844. Estimates vary from a peak of $5.917 to a trough of $0.8518, indicating an +103.88% surge from the present price of $1.66.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $5.6699 | $4.6996 | $5.2999 | +241.56% |
February, 2026 | $6.117 | $6.0567 | $5.917 | +268.50% |
March, 2026 | $4.0542 | $5.0342 | $5.5838 | +144.23% |
April, 2026 | $0.618 | $0.8518 | $3.8209 | -62.77% |
May, 2026 | $3.4251 | $3.0848 | $2.9251 | +106.33% |
June, 2026 | $3.5923 | $3.7923 | $4.0787 | +116.40% |
July, 2026 | $5.1461 | $4.549 | $4.7161 | +210.01% |
August, 2026 | $3.1432 | $4.0982 | $4.7729 | +89.35% |
September, 2026 | $4.1571 | $3.7036 | $3.6871 | +150.43% |
October, 2026 | $4.2342 | $4.5142 | $4.2107 | +155.07% |
November, 2026 | $4.8213 | $5.0013 | $4.5978 | +190.44% |
December, 2026 | $4.9452 | $5.0349 | $4.7485 | +197.91% |
Accelerate Diagnostics Inc Stock (AXDX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Accelerate Diagnostics Inc (AXDX) is $6.0461, with a high forecast of $7.6695 and a low forecast of $4.4227. This indicates an +264.22% increase from the last price of $1.66.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $4.4723 | $4.5023 | $4.602 | +169.42% |
February, 2027 | $5.0694 | $4.4227 | $4.3091 | +205.39% |
March, 2027 | $4.9333 | $5.1862 | $4.9766 | +197.19% |
April, 2027 | $5.5804 | $5.1269 | $5.1004 | +236.17% |
May, 2027 | $6.5325 | $6.0672 | $6.1208 | +293.53% |
June, 2027 | $6.7714 | $6.6347 | $6.5979 | +307.92% |
July, 2027 | $7.4185 | $7.2732 | $7.2685 | +346.90% |
August, 2027 | $7.6456 | $7.3953 | $7.5257 | +360.58% |
September, 2027 | $7.6858 | $7.7063 | $7.6695 | +363.00% |
October, 2027 | $7.1666 | $7.4566 | $7.4763 | +331.73% |
November, 2027 | $6.6138 | $6.7838 | $6.767 | +298.42% |
December, 2027 | $5.3476 | $5.7876 | $6.2505 | +222.15% |
Accelerate Diagnostics Inc Stock (AXDX) Price Forecast for 2028
In 2028, Accelerate Diagnostics Inc (AXDX) is projected to reach an average price of $4.554, with a high projection of $5.598 and a low estimate of $3.5101. This indicates an +174.34% rise from the last price of $1.66.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $5.5847 | $5.6446 | $5.598 | +236.43% |
February, 2028 | $5.4419 | $5.4469 | $5.2515 | +227.82% |
March, 2028 | $5.3757 | $5.2722 | $5.389 | +223.84% |
April, 2028 | $5.4321 | $5.2893 | $5.3928 | +227.24% |
May, 2028 | $5.5045 | $5.4773 | $5.399 | +231.60% |
June, 2028 | $5.1205 | $5.1388 | $5.3075 | +208.47% |
July, 2028 | $4.9559 | $4.9709 | $4.9606 | +198.55% |
August, 2028 | $4.7833 | $4.8047 | $4.8513 | +188.15% |
September, 2028 | $4.2819 | $4.4019 | $4.6087 | +157.95% |
October, 2028 | $3.9391 | $3.9791 | $4.2187 | +137.29% |
November, 2028 | $3.6829 | $3.7423 | $3.8665 | +121.86% |
December, 2028 | $3.37 | $3.5101 | $3.5595 | +103.01% |
Accelerate Diagnostics Inc Stock (AXDX) Price Forecast for 2029
The 2029 price forecast for Accelerate Diagnostics Inc Stock (AXDX) is $9.0353 on average, with a high prediction of $17.99 and a low estimate of $0.0757. This represents an +444.30% increase from the previous price of $1.66.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $2.7961 | $1.8628 | $4.6664 | +68.44% |
February, 2029 | $3.149 | $2.7193 | $3.7991 | +89.70% |
March, 2029 | $2.7819 | $2.7819 | $3.7654 | +67.58% |
April, 2029 | $2.7747 | $1.7752 | $3.8947 | +67.15% |
May, 2029 | $2.9409 | $2.458 | $3.4112 | +77.16% |
June, 2029 | $1.7538 | $1.2105 | $3.0541 | +5.65% |
July, 2029 | $1.6366 | $1.4412 | $2.757 | -1.41% |
August, 2029 | $0.6372 | $0.6691 | $2.0199 | -61.61% |
September, 2029 | $0.7443 | $0.6776 | $0.534 | -55.16% |
October, 2029 | $0.4082 | $0.4485 | $0.6048 | -75.41% |
November, 2029 | $0.2863 | $0.3786 | $0.3015 | -82.75% |
December, 2029 | $18.54 | $0.0757 | $17.99 | +1,017% |
Accelerate Diagnostics Inc Stock (AXDX) Price Forecast for 2030
Accelerate Diagnostics Inc Stock (AXDX) is expected to reach an average price of $19.95 in 2030, with a high forecast of $24.21 and a low forecast of $15.70. This signifies an +1,102% surge from the last price of $1.66.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $18.60 | $18.94 | $18.94 | +1,020% |
February, 2030 | $18.72 | $15.70 | $17.51 | +1,028% |
March, 2030 | $19.96 | $18.94 | $18.31 | +1,102% |
April, 2030 | $18.15 | $19.29 | $19.34 | +993.40% |
May, 2030 | $17.57 | $17.45 | $17.56 | +958.63% |
June, 2030 | $18.14 | $18.71 | $17.58 | +992.92% |
July, 2030 | $19.33 | $19.40 | $19.20 | +1,064% |
August, 2030 | $17.49 | $18.50 | $18.81 | +953.88% |
September, 2030 | $15.71 | $17.22 | $17.04 | +846.30% |
October, 2030 | $16.86 | $16.91 | $16.79 | +915.44% |
November, 2030 | $23.68 | $17.48 | $20.95 | +1,327% |
December, 2030 | $24.97 | $24.76 | $24.21 | +1,405% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):